+49 30 648 35 164 service@chameleon-pharma.com

CPhI SEA 2022: How to enter the European Rx. & OTC Market in a systematic way and how to receive EU GMP

Featured Picture: Photo by Elijah G on Unsplash

From Asia to Europe and Latin America – everything you should know about market Rx. and OTC market entry, the process to receive the EU GMP certificate and product registration in Europe. Join us for our CPC presentation on the CPHI South East Asia on 19. October 2022 in Bangkok.

CPhI South East Asia is one of the biggest OTC and pharma conferences in the region. This year, the CPhI South East Asia will take place at IMPACT, in Bangkok, between the 19th and 21st of October 2022. CPC Expert Presentation on How to enter the European Rx. & OTC Market in a systematic way and how to receive EU GMP.

We, at Chameleon Pharma Consulting Group (CPC), are healthcare experts focused on Systematic Market Entry in Europe, CIS/CEE, Latin America, Asia, US/Canada, and the Middle East. Our more than 20 years of practical experience in 300 successful projects in the self-medication and Rx industry allow us to help pharma and OTC companies enter new markets, develop market entry strategies, create product portfolios for selected markets and overcome regulatory requirements more efficiently. With our knowledge and our extensive network of experts, we can guarantee a dynamic, flexible, and customer-oriented service.

Mr. Reiner Christensen, the CEO of Chameleon Pharma Consulting will attend the CPHI conference with a speech on:

“From Asia to Europe How to enter the European Rx. & OTC Market in a systematic way and how to receive EU GMP.”

The speech will focus on the following themes:

  • Systematic Market Entry for your Rx. & OTC Market in Europe
  • Receive the EU GMP certificate for your plant
  • Participate in European Rx. private & government tenders
  • Product registration in Europe
  • Country Focus Germany

 

We look forward to meeting you in person in Bangkok. In the meantime, don’t hesitate to contact us if you have any questions regarding Market Entry, GMP Certificates, Licensing and M&A, Registration, Systematic International Partner Company Search,…

Contact us

3 + 12 =

Related Posts

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s large maternal care base continues to support demand for pregnancy supplements and women’s health products. According to INEGI, Mexico registered 1.67 million births in 2024, equal to 47.7 births per 1,000 women of fertile age. This creates regular demand for prenatal vitamins, folic acid, iron, calcium, DHA, and other Food Supplements supporting pregnancy, maternal wellbeing, and postpartum recovery.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis